Just on your question, imo they are now a very professionally run organisation and orientated to sound management principles which means that the announcements will only be made with all the details have been finalised and the company arranged a deal that is financially in the long term interest of DDT IMO confidentiality with the phamaceutical company would have been requested by them hence the limited announcement by DDT. IMO there would have been some very impressive details that DDt would like to have disclosed but due to the negotiations were not able to. It must be a very important milestone and opens up a totally new market for the company. Also offers opportunities for adopting the DDT technology to a range of other pharmaceutical products. What is not being taken into consideration by the market at the moment is the strong financial position, contracts already in place for future revenue and the ever developing DDT technology. For a small cap company it is in very good shape with it foot in the door of the global security market. Sure the traders will play with the SP but the longer term holders will be the beneficiaries as when this type of stock gets "interest" the movement tends to be very positive. Anyway I remain bullish.
DDT Price at posting:
4.7¢ Sentiment: Buy Disclosure: Held
